Temasek-backed ClavystBio co-leads Allay Therapeutics' Series D

Temasek-backed ClavystBio co-leads Allay Therapeutics' Series D

Katrina Bianca Cuaresma

06 June, 2025

Edited by: Padma Priya

allay therapeutics ClavystBio HealthTech Lightstone Ventures Temasek

Printed by Unregistered user on Sat, 06 Sep 2025 00:22:12 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

We’re starting to see first-in-class IP coming out of Singapore, says ClavystBio’s Khoo Shih

Venture Capital

Singapore-based biotech startup Automera bags $16m in Series A funding

Read more from Singapore

Asia Digest: Fullerton, Da Cheng sign deal; Daiwa Securities invests in DCG; VPBankS mulls IPO

Venture Capital

RushOwl raises $10m in Series A round led by Gobi Partners